Abstract
The combination of resection of infected tissue and antifungal therapy is the treatment of choice in mucormycosis. In disseminated mucormycosis, where surgery is impossible, the mortality is almost 90%. We report the first case of disseminated mucormycosis that was cured with a combination therapy of liposomal amphotericin B and posaconazole without surgical intervention.
MeSH terms
-
Amphotericin B / therapeutic use*
-
Antifungal Agents / therapeutic use*
-
Drug Therapy, Combination
-
Female
-
Humans
-
Leukemia, Myeloid, Acute / complications*
-
Liposomes / therapeutic use*
-
Middle Aged
-
Mucormycosis / drug therapy*
-
Rhizomucor / classification
-
Rhizomucor / genetics
-
Rhizomucor / isolation & purification*
-
Treatment Outcome
-
Triazoles / therapeutic use*
Substances
-
Antifungal Agents
-
Liposomes
-
Triazoles
-
liposomal amphotericin B
-
posaconazole
-
Amphotericin B